Valibose

CAS NO.：83470-79-5
Empirical Formula: C10H21NO6
Molecular Weight: 251.28
Update Date: 2026-05-22 09:14:11

What is Valibose?

Description

Valibose An α-glucosidase inhibitor potentially for the treatment of diabetes. Valibose significantly decreased postprandial and fasting blood glucose, urine glucose, and reduced the levels of serum fructosamine. Valibose also decreased plasma triglyceride and cholesterol levels. Valibose ameliorated metabolic disturbance of glucose and lipids. In addition, valibose markedly reduced level of serum NAG and BUN, and decreased the weight index of kidney.

Properties of Valibose

Boiling point:	583.1±50.0 °C(Predicted)
Density	1.46±0.1 g/cm3(Predicted)
pka	13.92±0.70(Predicted)

Safety information for Valibose

Computed Descriptors for Valibose

New Products

6-Hydroxy-2,4-Diaminopyrimidine 2,6-Dipicolic Acid 3-AMINO-3-(2-CHLORO-PHENYL)-PROPIONIC ACID 4-Fluorophenylglycine 1-N-Boc-3-(aminoethyl)azetidine Dimedone 1-Boc-3-(cyanomethyl)azetidine N-BOC-piperidine-4-carboxylic acid 3-Hydroxypyridine 2-Bromo-5-Chloro-3-Nitropyridine 2-Amino-3-Nitro-5-Chloro Pyridine 2-Amino-5-Iodopyridine 5-Amino-2-Hydroxypyridine 2,5-Dibromopyridine 2-BROMOACETYL BROMIDE-D2 METHANE SULFONIC ACID-D4 PHOSPORIC ACID-D3 85 W% IN D2O DEUTERIUM OXIDE FOR NMR BENZENE-D6 TOLUENE-D3 5-Acetylsalicylamide 1-(3-Chlorophenyl)-4-(3-Chloropropyl) piperazine hydrochloride 4-(Methyl amino)-3-Nitro benzoic acid 3,4,5-Trimethoxy benzoic acid